malondialdehyde has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Guan, P; Han, L; Hu, C; Huang, X; Mu, Y; Qu, X; Su, H | 1 |
| Akbulut, G; Aksakal, FN; Bulduk, E; Gonul, B; Kalkanci, A; Kustimur, S; Yetkin, I | 1 |
2 other study(ies) available for malondialdehyde and Candidiasis
| Article | Year |
|---|---|
A semisynthetic borrelidin analogue BN-3b exerts potent antifungal activity against Candida albicans through ROS-mediated oxidative damage.
Topics: Adenosine Triphosphate; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Down-Regulation; Fatty Alcohols; Glutathione; Glutathione Disulfide; Hyphae; Invasive Fungal Infections; Malondialdehyde; Mice; Reactive Oxygen Species; Structure-Activity Relationship; Virulence Factors | 2020 |
The effect of vaginal candidiasis on the levels of the oxidative biomarkers in plasma and tissue samples of diabetic rats.
Topics: Animals; Ascorbic Acid; Biomarkers; Blood Glucose; Candidiasis; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Glutathione; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Streptozocin; Vaginal Diseases | 2007 |